Clinical Trial

Registry of Management Strategies for Patients With COVID-19 in Healthcare Establishments

Study acronym: HOPICOV
Unknown
View on ClinicalTrials.gov →
Summary
The purpose of the study is to describe medical care strategies implemented by healthcare establishments for patients affected by COVID-19
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05069389
Lead Sponsor Centre Hospitalier Emile Roux
Collaborators: Médipôle Lyon-Villeurbanne, Centre Hospitalier Memorial France Etats-Unis, Centre Hospitalier de Valence, Centre Hospitalier de Troyes, Groupe Hospitalier de la Rochelle Ré Aunis, Centre Hospitalier William Morey - Chalon sur Saône, Centre Hospitalier de Saint-Malo, Centre Hospitalier Intercommunal de Mont de Marsan, Centre Hospitalier Intercommunal de Poissy / Saint-Germain, Centre Hospitalier de Dax, Centre Hospitalier Public du Cotentin, Centre Hospitalier Henri Duffaut - Avignon, Boulogne sur Mer Hospital Center, Centre Hospitalier Louis Pasteur, Chartres, Centre Hospitalier de Montauban, Centre Hospitalier de Saint-Brieuc, Groupe Hospitalier Aube Marne
Conditions COVID-19 Infection
Enrollment 2,071 participants
Start Date 2020-06-02
Primary Completion 2023-12-31 (estimated)
Study Completion 2025-07-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-08